Literature DB >> 24604142

Corticosteroids and vestibular exercises in vestibular neuritis. Single-blind randomized clinical trial.

John K Goudakos, Konstantinos D Markou, George Psillas, Victor Vital, Miltiadis Tsaligopoulos.   

Abstract

IMPORTANCE The management of patients with unilateral acute vestibular neuritis (VN) has not been established to date. OBJECTIVE To compare the use of vestibular exercises vs corticosteroid therapy in the recovery of patients with acute VN. DESIGN, SETTING, AND PARTICIPANTS Prospective, single-blind, randomized clinical trial at a primary referral center. Among all patients with acute vertigo, those having VN were eligible for inclusion in the study. INTERVENTIONS Forty patients with acute VN were randomly assigned to perform vestibular exercises or to receive corticosteroid therapy. After a baseline examination, follow-up evaluations were performed at 1, 6, and 12 months. MAIN OUTCOMES AND MEASURES Efficacy outcomes included clinical, canal, and otolith recovery. Scores on the European Evaluation of Vertigo Scale and the Dizziness Handicap Inventory were used for the evaluation of clinical recovery. Findings of caloric irrigation and vestibular evoked myogenic potentials indicated canal and otolith improvement, respectively. RESULTS Comparing the 2 treatment groups, no statistically significant differences were found in clinical, canal, or otolith recovery. At the 6-month examination, the number of patients with complete disease resolution in the corticosteroids group was significantly higher than that in the vestibular exercises group. However, at the end of the follow-up period, 45%(9 of 20) of patients in the vestibular exercises group and 50% (10 of 20) of patients in the corticosteroids group had complete disease resolution (P > .05). CONCLUSIONS AND RELEVANCE Treating patients who have acute VN with vestibular exercises seems equivalently effective as treating them with corticosteroid therapy in clinical, caloric, and otolith recovery. Corticosteroid therapy seems to enhance earlier complete acute VN resolution, with no added benefit in the long-term prognosis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24604142     DOI: 10.1001/jamaoto.2014.48

Source DB:  PubMed          Journal:  JAMA Otolaryngol Head Neck Surg        ISSN: 2168-6181            Impact factor:   6.223


  10 in total

1.  Recent Evidence About the Effectiveness of Vestibular Rehabilitation.

Authors:  Susan L Whitney; Ahmad H Alghadir; Shahnawaz Anwer
Journal:  Curr Treat Options Neurol       Date:  2016-03       Impact factor: 3.598

2.  Effect of the novel histamine H4 receptor antagonist SENS-111 on spontaneous nystagmus in a rat model of acute unilateral vestibular loss.

Authors:  Mathieu Petremann; Cindy Gueguen; Viviana Delgado Betancourt; Eric Wersinger; Jonas Dyhrfjeld-Johnsen
Journal:  Br J Pharmacol       Date:  2019-08-28       Impact factor: 8.739

3.  Safety, tolerability, pharmacokinetics and pharmacokinetic-pharmacodynamic modelling of the novel H4 receptor inhibitor SENS-111 using a modified caloric test in healthy subjects.

Authors:  Frédéric Venail; Pierre Attali; Eric Wersinger; Roberto Gomeni; Sonia Poli; Sebastien Schmerber
Journal:  Br J Clin Pharmacol       Date:  2018-10-01       Impact factor: 4.335

4.  Efficacy of steroid therapy based on symptomatic and functional improvement in patients with vestibular neuritis: a prospective randomized controlled trial.

Authors:  Myung Hoon Yoo; Chan Joo Yang; Shin Ae Kim; Marn Joon Park; Joong Ho Ahn; Jong Woo Chung; Hong Ju Park
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-04-08       Impact factor: 2.503

Review 5.  Management of peripheral vertigo with antihistamines: New options on the horizon.

Authors:  Jonas Dyhrfjeld-Johnsen; Pierre Attali
Journal:  Br J Clin Pharmacol       Date:  2019-07-22       Impact factor: 4.335

6.  Corticosteroids versus vestibular rehabilitation in long-term outcomes in vestibular neuritis.

Authors:  Elshahat Ibrahem Ismail; Ashraf Elsayed Morgan; Akram Mohamed Abdel Rahman
Journal:  J Vestib Res       Date:  2018       Impact factor: 2.354

Review 7.  Neuro-otology- some recent clinical advances.

Authors:  Miriam S Welgampola; Gülden Akdal; G Michael Halmagyi
Journal:  J Neurol       Date:  2016-09-15       Impact factor: 4.849

8.  Breaking a dogma: acute anti-inflammatory treatment alters both post-lesional functional recovery and endogenous adaptive plasticity mechanisms in a rodent model of acute peripheral vestibulopathy.

Authors:  Nada El Mahmoudi; Guillaume Rastoldo; Emna Marouane; David Péricat; Isabelle Watabe; Alain Tonetto; Charlotte Hautefort; Christian Chabbert; Francesca Sargolini; Brahim Tighilet
Journal:  J Neuroinflammation       Date:  2021-08-21       Impact factor: 8.322

9.  Current diagnosis and treatment of vestibular neuritis: a narrative review.

Authors:  Chang Hoon Bae; Hyung Gyun Na; Yoon Seok Choi
Journal:  J Yeungnam Med Sci       Date:  2021-08-09

Review 10.  The pharmacological treatment of acute vestibular syndrome.

Authors:  Pasquale Viola; Federico Maria Gioacchini; Alessia Astorina; Davide Pisani; Alfonso Scarpa; Gianmarco Marcianò; Alessandro Casarella; Emanuele Basile; Vincenzo Rania; Massimo Re; Giuseppe Chiarella
Journal:  Front Neurol       Date:  2022-09-09       Impact factor: 4.086

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.